Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study

A Sturdza, R Pötter, LU Fokdal, C Haie-Meder… - Radiotherapy and …, 2016 - Elsevier
Purpose Image guided brachytherapy (IGBT) for locally advanced cervical cancer allows
dose escalation to the high-risk clinical target volume (HRCTV) while sparing organs at risk …

Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer …

L Fokdal, A Sturdza, R Mazeron, C Haie-Meder… - Radiotherapy and …, 2016 - Elsevier
Background and purpose Image guided adaptive brachytherapy (IGABT) using intracavitary
applicators (IC) has led to a significant improvement of local control in locally advanced …

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

ASVM Van Den Heerik, N Horeweg, RA Nout… - International Journal of …, 2020 - ijgc.bmj.com
Background Vaginal brachytherapy is currently recommended as adjuvant treatment in
patients with high-intermediate risk endometrial cancer to maximize local control and has …

Assessment and management of radiotherapy induced toxicity in older patients

A O'Donovan, M Leech, C Gillham - Journal of geriatric oncology, 2017 - Elsevier
Radiotherapy is an attractive treatment option for older adults, especially where surgery and
chemotherapy pose too great a risk. Radiotherapy toxicity may be divided into acute/early …

Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)

L Walsh, C Gillham, M Dunne, I Fraser… - Radiotherapy and …, 2011 - Elsevier
We retrospectively reviewed acute toxicity with cetuximab and radiotherapy, comparing it
with a matched cisplatin group. The cetuximab group experienced significantly more toxicity …

Change in patterns of failure after image-guided brachytherapy for cervical cancer: analysis from the RetroEMBRACE study

LT Tan, R Pötter, A Sturdza, L Fokdal… - International Journal of …, 2019 - Elsevier
Purpose Image guided adaptive brachytherapy (IGABT) for cervical cancer improves pelvic
control and survival across all stages. Improvement in pelvic control is larger in advanced …

Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer

SG Maher, CM Gillham, SP Duggan, PC Smyth… - Annals of …, 2009 - journals.lww.com
Objective: This study explored gene expression differences in predicting response to
chemoradiotherapy in esophageal cancer. Purpose: A major pathological response to …

Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?

A Abramyuk, S Tokalov, K Zöphel, A Koch… - Radiotherapy and …, 2009 - Elsevier
BACKGROUND AND PURPOSE: Local failure is a significant issue following radiotherapy
(RT) for patients with non-small cell lung cancer (NSCLC). The aim of this study was to find …

Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature

MR Boland, T Nugent, J Nolan, J O'Mahony, S O'Keeffe… - Breast Cancer, 2021 - Springer
Background Breast fibromatosis is a rare clinical entity, but poses significant diagnostic and
therapeutic challenges. In light of recent changes in management practices, the aim was to …

Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

C Gillham, D Zips, F Pönisch, C Evers… - Radiotherapy and …, 2008 - Elsevier
BACKGROUND AND PURPOSE: Loco-regional failure after radiotherapy with total doses of
60–70 Gy for non-small cell lung cancer (NSCLC) remains a major clinical problem …